 - disease at screening other than NAFLD such as relevant cardiovascular, gastrointestinal, hepatic, neurologic, psychiatric, endocrine i.e. pancreatic except T2DM, hematologic, malignant, infection or other major systemic diseases making implementation of the protocol or interpretation of the study results difficult 